4:07 PM
 | 
Apr 05, 2013
 |  BC Extra  |  Politics & Policy

IOM to provide guideline on data transparency

The Institute of Medicine said it plans to conduct a study later this year for strategies on how to responsibly share clinical trial data. The institute will seek input from a group of stakeholders -- including industry, patient groups, academic institutions and government and regulatory agencies -- to develop guidelines for...

Read the full 233 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >